Literature DB >> 15850924

Dual responsive promoters to target therapeutic gene expression to radiation-resistant hypoxic tumor cells.

Naomi Chadderton1, Rachel L Cowen, Freda C D Sheppard, Suzanne Robinson, Olga Greco, Simon D Scott, Ian J Stratford, Adam V Patterson, Kaye J Williams.   

Abstract

PURPOSE: Tumor hypoxia is unequivocally linked to poor radiotherapy outcome. This study aimed to identify enhancer sequences that respond maximally to a combination of radiation and hypoxia for use in genetic radiotherapy approaches. METHODS AND MATERIALS: The influence of radiation (5 Gy) and hypoxia (1% O2) on reporter-gene expression driven by hypoxia (HRE) and radiation (Egr-1) responsive elements was evaluated in tumor cells grown as monolayers or multicellular spheroids. Hypoxia-inducible factor-1alpha (HIF-1alpha) and HIF-2alpha protein expression was monitored in parallel.
RESULTS: Of the sequences tested, an HRE from the phosphoglycerate kinase-1 gene (PGK-18[5+]) was maximally induced in response to hypoxia plus radiation in all 5 cell lines tested. The additional radiation treatment afforded a significant increase in the induction of PGK-18[5+] compared with hypoxia alone in 3 cell lines. HIF-1alpha/2alpha were induced by radiation but combined hypoxia/radiation treatment did not yield a further increase. The dual responsive nature of HREs was maintained when spheroids were irradiated after delivery of HRE constructs in a replication-deficient adenovirus.
CONCLUSIONS: Hypoxia-responsive enhancer element sequences are dually responsive to combined radiation and hypoxic treatment. Their use in genetic radiotherapy in vivo could maximize expression in the most radio-resistant population at the time of radiation and also exploit microenvironmental changes after radiotherapy to yield additional switch-on.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15850924     DOI: 10.1016/j.ijrobp.2005.01.031

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

1.  Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells.

Authors:  Suvobroto Nandi; Ilya V Ulasov; Matthew A Tyler; Adam Quasar Sugihara; Luciana Molinero; Yu Han; Zeng B Zhu; Maciej S Lesniak
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

2.  Hypoxia-inducible factor in thyroid carcinoma.

Authors:  Natalie Burrows; Muhammad Babur; Julia Resch; Kaye J Williams; Georg Brabant
Journal:  J Thyroid Res       Date:  2011-06-16

Review 3.  Fatty Acids and Calcium Regulation in Prostate Cancer.

Authors:  Ivan V Maly; Wilma A Hofmann
Journal:  Nutrients       Date:  2018-06-19       Impact factor: 5.717

4.  Expression of hypoxia-inducible factor 1 alpha in thyroid carcinomas.

Authors:  N Burrows; J Resch; R L Cowen; R von Wasielewski; C Hoang-Vu; C M West; K J Williams; G Brabant
Journal:  Endocr Relat Cancer       Date:  2010-01-29       Impact factor: 5.678

5.  Induction of plasminogen activator inhibitor type-1 (PAI-1) by hypoxia and irradiation in human head and neck carcinoma cell lines.

Authors:  Daniela Schilling; Christine Bayer; Anneke Geurts-Moespot; Fred C G J Sweep; Martin Pruschy; Karin Mengele; Lisa D Sprague; Michael Molls
Journal:  BMC Cancer       Date:  2007-07-30       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.